Maximum quantity allowed is 999
Please select the quantity
CAS RN: 947669-91-2 | Product Number: W0025
WWL 70
×
![]()
×
Purity: >95.0%(HPLC)(qNMR)
Synonyms:
- 4'-Carbamoyl-[1,1'-biphenyl]-4-yl Methyl[3-(pyridin-4-yl)benzyl]carbamate
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 10MG |
$137.00
|
≥40 | 0 | Contact Us |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | W0025 |
| Purity / Analysis Method | >95.0%(HPLC)(qNMR) |
| Molecular Formula / Molecular Weight | C__2__7H__2__3N__3O__3 = 437.50 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive,Hygroscopic |
| CAS RN | 947669-91-2 |
| Reaxys Registry Number | 11185410 |
| MDL Number | MFCD10567112 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 95.0 area% |
| Purity(qNMR) | min. 95.0 % |
| NMR | confirm to structure |
Properties (reference)
GHS
Related Laws:
Transport Information:
| H.S.code* | 2933.39-000 |
Application
WWL 70: A Potent and Selective Inhibitor of ABHD6
Endogenous cannabinoids, such as anandamide [A3448] and 2-arachidonoyl glycerol (2-AG) [A3490], are biologically active lipids that activate the cannabinoid receptors CB1 and CB2. Cannabinoid receptors, located throughout the body, are part of the endocannabinoid system (ECS), which is involved in a variety of physiological processes.1) Endocannabinoid signaling is terminated by enzymatic hydrolysis, a process that for anandamide is mediated by fatty acid amide hydrolase (FAAH), and for 2-AG is thought to involve monoacylglycerol lipase (MAGL) and Abhydrolase Domain Containing 6 (ABHD6). WWL 70 is a potent and selective inhibitor of ABHD6 and has been reported to raise mice brain 2-AG levels without altering anandamide and to attenuate neuropathic pain.2-4) (The product is for research use only.)
References
- 1) An Introduction to the Endogenous Cannabinoid System
- 2) Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis
- 3) WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor independent mechanisms
- 4) WWL70 attenuates PGE2 production derived from 2-arachidonoylglycerol in microglia by ABHD6-independent mechanism
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.